Press Releases

Shilpa Biologicals Launches Integrated ADC Production Site in India

Yuvraj — Wed, 01 Jul 2026 06:02:32 +0000

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd, has officially commissioned an advanced integrated Antibody–Drug Conjugate (ADC) GMP manufacturing site in Dharwad. Announced on 25 June 2026, the facility was specifically engineered to satisfy the rigorous global regulatory standards of the US FDA, EMA, and other prominent health authorities. This ADC manufacturing facility is […]

The post Shilpa Biologicals Launches Integrated ADC Production Site in India first appeared on World Pharma Today.

CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing

Yuvraj — Wed, 01 Jul 2026 05:42:24 +0000

CPHI Milan 2026, recognized as a premier global gathering for the pharmaceutical industry, has announced the introduction of four new specialist zones for pharma at its upcoming event. Scheduled for October 6-8, 2026, at the Fiera Milan exhibition centre in Rho, Italy, these specialized areas will focus on AI & Tech, Cold Chain & Logistics, […]

The post CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing first appeared on World Pharma Today.

Sanofi Partners with Pangaea for AI-Driven AATD Detection

Yuvraj — Wed, 24 Jun 2026 13:41:26 +0000

Pangaea Data (Pangaea), a provider of a guideline-configured AI platform designed to help close care gaps and improve the identification of untreated and under-treated patients with difficult-to-diagnose conditions, has entered into a collaboration agreement with Sanofi. Under the arrangement, Pangaea’s technology will be deployed across a group of large health systems in the United States […]

The post Sanofi Partners with Pangaea for AI-Driven AATD Detection first appeared on World Pharma Today.

Shilpa Biologicals Launches PartnerPower Platform for CDMOs

Yuvraj — Wed, 24 Jun 2026 08:54:08 +0000

Shilpa Biologicals Pvt. Ltd. (SBPL) has introduced PartnerPower Platform, a proprietary digital transparency solution designed to provide global sponsors with continuous, real-time visibility across biologics development and manufacturing activities. Announced on 22 June 2026 from Dharwad, India, the platform is intended to give biopharmaceutical innovators uninterrupted access to project information, enabling them to monitor progress […]

The post Shilpa Biologicals Launches PartnerPower Platform for CDMOs first appeared on World Pharma Today.

Alcami Strengthens Tennessee Facility with Quality, Packaging and Storage Capacity

Yuvraj — Fri, 19 Jun 2026 08:49:26 +0000

Alcami Corporation has announced a series of strategic investments at its Tennessee facility, a site that recently became part of the company’s network through the acquisition of Tjoapack. The initiative is aimed at strengthening operations across quality, packaging, storage, and workforce capabilities as the contract development and manufacturing organization continues to expand its integrated service […]

The post Alcami Strengthens Tennessee Facility with Quality, Packaging and Storage Capacity first appeared on World Pharma Today.

MGS Advances Healthcare Product Development with Hybrid Tooling

Yuvraj — Sat, 13 Jun 2026 05:41:10 +0000

MGS, a healthcare-focused contract development and manufacturing organization, has expanded its Hybrid Tooling capability worldwide after successfully deploying the approach alongside its A.i.r. Platform™. The company said the broader rollout is intended to help healthcare manufacturers accelerate product development, lower development risks and progress from concept to commercialization with greater confidence. The expanded offering is […]

The post MGS Advances Healthcare Product Development with Hybrid Tooling first appeared on World Pharma Today.

Aptar Advances Pharmaceutical Packaging as N-Sorb Technology Gains Patent Approval

Yuvraj — Sat, 13 Jun 2026 05:18:22 +0000

Aptar Active Material Science, a division of AptarGroup, Inc., has reached an important intellectual property milestone after receiving approval from the United States Patent and Trademark Office (USPTO) for its foundational U.S. patent application covering N-Sorb Technology. Announced on June 9, 2026, the development strengthens the company’s nitrosamine risk mitigation platform and introduces a packaging-based […]

The post Aptar Advances Pharmaceutical Packaging as N-Sorb Technology Gains Patent Approval first appeared on World Pharma Today.

CPHI Americas Relocates to Miami to Strengthen Global Industry Connectivity

Yuvraj — Thu, 04 Jun 2026 09:43:13 +0000

Informa Markets has announced that CPHI Americas will relocate to Miami in 2027, marking a significant step in the event’s ongoing development as a platform for pharmaceutical innovation, outsourcing and strategic partnerships. Scheduled for May 25-26, 2027, at the Miami Convention Center, the move is intended to improve international accessibility, encourage greater executive participation and […]

The post CPHI Americas Relocates to Miami to Strengthen Global Industry Connectivity first appeared on World Pharma Today.

Aragen Achieves Daretabart Commercial-scale GMP Production

Yuvraj — Wed, 03 Jun 2026 11:50:39 +0000

Aragen, a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has announced the successful technology transfer and commercial-scale GMP manufacturing of the first batches of Daretabart, Renaissance Pharma’s lead therapeutic candidate for high-risk neuroblastoma. The milestone was achieved within just nine months, highlighting the efficiency of the collaboration between the two organizations. […]

The post Aragen Achieves Daretabart Commercial-scale GMP Production first appeared on World Pharma Today.

Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe

Yuvraj — Mon, 01 Jun 2026 05:48:10 +0000

Nestlé Health Science and IdB Holding have officially announced a VOWST licensing agreement to develop and commercialize the oral therapy in Europe, subject to approval by the European Medicines Agency (EMA). This collaboration aims to expand European patient access to therapies preventing recurrent Clostridioides difficile infection, a severe gastrointestinal condition with limited management options. Currently […]

The post Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe first appeared on World Pharma Today.